Medicare Advantage Policy
Expert articles and analysis related to medicare advantage policy.
AI Summary — Last 30 Days
In the past month, the Trump administration has initiated a significant shift in Medicare Advantage (MA) policy, aiming to keep MA payment rates flat and recalibrating risk adjustment calculations, as detailed by CMS. This move has generated considerable pushback from insurers, evidenced by a record number of comments submitted regarding these proposed changes, reflecting the inherent tensions between CMS and MA stakeholders over cost control and service delivery quality. Additionally, Humana's recent introduction of value-based cardiac care partnerships positions it strategically to enhance member care while also confronting emerging challenges related to MA overpayments, which are contributing to rising Part B premiums for beneficiaries, as reported by the Joint Economic Committee. Stakeholders must navigate these developments carefully to sustain their competitive edge in this evolving landscape.
For more details, see CMS receives record comments on controversial Medicare Advantage payment proposal and [Humana's Cardiac Care Push Revealing Its Next Edge in Medicare Advantage](https://news.google.com/rss/articles/CBMiygFBVV95cUxQb0IyYzlibGV4cDZLVlNWMzExZk43anpOLTVHWG1WSzdnU3ZkX0J6RGt5UnI1Y0hEcTUySWdWLVpYaGlyTmdWTWt5a1Jl
Related Articles
Oversight shrinks Medicare Advantage payment gap to $76B: MedPAC
Oversight shrinks Medicare Advantage payment gap to $76B: MedPAC Modern Healthcare
CMS receives record comments on controversial Medicare Advantage payment proposal
The Trump administration wants to keep MA rates flat next year and change how risk adjustment is calculated. Insurers had a lot to say about this, CMS officials shared Tuesday during an event in D.C.
Humana Introduces New Value-Based Cardiology Care Partnerships for Medicare Advantage Members
Humana Introduces New Value-Based Cardiology Care Partnerships for Medicare Advantage Members Yahoo Finance
CMS threatens Elevance with Medicare Advantage sanctions
CMS threatens Elevance with Medicare Advantage sanctions Healthcare Dive
CMS threatens Elevance with Medicare Advantage sanctions
Federal regulators are planning to suspend enrollment in Elevance's MA plans at the end of March, in a rare and serious threat to the company’s finances.
Considerations for implementing Medicare Advantage encounter data in risk adjustment - MedPAC (.gov)
Considerations for implementing Medicare Advantage encounter data in risk adjustment MedPAC (.gov)
Considerations for implementing Medicare Advantage encounter data in risk adjustment - MedPAC (.gov)
Considerations for implementing Medicare Advantage encounter data in risk adjustment MedPAC (.gov)
Humana’s MaxHealth Deal Tests Medicare Advantage Strategy And Valuation Gap
Humana’s MaxHealth Deal Tests Medicare Advantage Strategy And Valuation Gap Yahoo Finance
The Value Shift – How Medicare Advantage Benefits Are Evolving for 2026
This updated paper builds on Wakely’s prior analysis of Medicare Advantage benefit design, incorporating newly released 2026 enrollment data to provide a clearer picture of how market dynamics are evo...
Flat 2027 Medicare Advantage Rates Signal Tighter Budgets—and Tougher Access Ahead
Flat 2027 Medicare Advantage Rates Signal Tighter Budgets—and Tougher Access Ahead Pharmaceutical Commerce